Benzodiazepine dependence: Focus on withdrawal syndrome Dépendance aux benzodiazépines : le syndrome de sevrage

[1]  G. Hulse,et al.  The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles , 2009, Journal of psychopharmacology.

[2]  M. Lader,et al.  Withdrawing Benzodiazepines in Primary Care , 2009, CNS Drugs.

[3]  P. Das,et al.  Increased AMPA receptor GluR1 subunit incorporation in rat hippocampal CA1 synapses during benzodiazepine withdrawal , 2008, The Journal of comparative neurology.

[4]  L. Greenfield,et al.  Chronic Benzodiazepine Administration Potentiates High Voltage-Activated Calcium Currents in Hippocampal CA1 Neurons , 2008, Journal of Pharmacology and Experimental Therapeutics.

[5]  J. Kornhuber,et al.  Neuroendocrine pathways in benzodiazepine dependence: new targets for research and therapy , 2008, Human psychopharmacology.

[6]  B. Källén,et al.  Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations , 2007, Pharmacoepidemiology and drug safety.

[7]  Andrea Cipriani,et al.  Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation , 2007, European Journal of Clinical Pharmacology.

[8]  M. Brandão,et al.  The blockade of AMPA-kainate and NMDA receptors in the dorsal periaqueductal gray reduces the effects of diazepam withdrawal in rats , 2007, Pharmacology Biochemistry and Behavior.

[9]  D. Gutman,et al.  The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal , 2007, Psychopharmacology.

[10]  F. Zitman,et al.  Strategies for discontinuing long-term benzodiazepine use , 2006, British Journal of Psychiatry.

[11]  E. Autret-Leca,et al.  Retentissement nonatal de l'exposition aux benzodiazpines en fin de grossesse , 2005 .

[12]  H. Ashton.  The diagnosis and management of benzodiazepine dependence , 2005, Current opinion in psychiatry.

[13]  C. O'brien.  Benzodiazepine use, abuse, and dependence. , 2005, The Journal of clinical psychiatry.

[14]  K. Wafford.  GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence? , 2005, Current opinion in pharmacology.

[15]  C. I. Neutel,et al.  The epidemiology of long-term benzodiazepine use , 2005, International review of psychiatry.

[16]  C. Nemeroff,et al.  Spontaneous Withdrawal from the Triazolobenzodiazepine Alprazolam Increases Cortical Corticotropin-Releasing Factor mRNA Expression , 2004, The Journal of Neuroscience.

[17]  Nicholas Moore,et al.  Patterns and correlates of benzodiazepine use in the French general population , 2004, European Journal of Clinical Pharmacology.

[18]  F. Holsboer,et al.  Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression , 2004, Psychoneuroendocrinology.

[19]  C. Morin,et al.  Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. , 2004, The American journal of psychiatry.

[20]  J. Holden,et al.  Benzodiazepine prescribing and withdrawal for 3234 patients in 15 general practices. , 1994, Family practice.

[21]  D. Kavanagh,et al.  Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. , 2009, Addiction.

[22]  M. Auriacombe,et al.  Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence. , 2009, Drug and alcohol dependence.

[23]  G. Birchley.  Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: a review of recent literature. , 2009, Nursing in critical care.